CALABRESE, ANDREW ANTONY,JEFFY, BRANDON DAVID,ROBINSON, DALE,ZHU, DAN,HUANG, DEHUA,ELSNER, JAN,BOYLAN, JOHN FREDERICK,TEHRANI, LIDA,NAGY, MARK, A.,RAHEJA, RAJ, KUMAR,ERDMAN, PAUL,NARLA, RAMA, K.,HARRI
申请号：
HK16100005.5
公开号：
HK1212207A
申请日:
2016.01.04
申请国别(地区):
HK
年份:
2016
代理人:
摘要：
The present invention relates to a compound of formula (I): and pharmaceutically acceptable salts, tautomers, stereoisomers, enantiomers, and isotopologues thereof, wherein R 1 , R 2 , R 3 and L are as defined herein. Also provided is a compound or a pharmaceutical composition of the present invention for use in a method for treating or preventing breast cancer.
